Roche yesterday outlined its initiative to reshape its Pharmaceuticals Division for the future. The initiative aims to increase sales and reduce the division's cost structure in order to improve the long-term profitability of the Pharmaceuticals Division. World-wide Roche expects job reductions in the range of 3000 over the next two to three years. Main sites affected are Palo Alto and Nutley, US, Welwyn, UK, and Basel, Switzerland. Roche is committed to conducting the restructuring process in a socially responsible manner and to keeping redundancies to a minimum.